24 results
DRS/A
EX-10
CHRS
Coherus Biosciences Inc
5 Aug 14
Draft registration statement (amended)
12:00am
shall not be obliged to transfer any Manufacturing technology, including without limitation, cell lines, cell culture and product purification
424B5
CHRS
Coherus Biosciences Inc
23 May 18
Prospectus supplement for primary offering
5:27pm
parent mouse antibody as bevacizumab and produced through a microbial culture. We have identified the amino acid sequence of CHS-3351 and confirmed
424B5
tzb82s3
21 May 18
Prospectus supplement for primary offering
5:20pm
10-K
drhumm44ls4d
23 Mar 15
Annual report
12:00am
DRS
s7hrfq6nl70xm9d72
4 Aug 14
Draft registration statement
12:00am